Products for Research Use Only
RegisterLogin

CDK8-IN-19

CAT: 0013-GTR19263111-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19263111-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK8-IN-19 (Compound 3d) is a CDK8 inhibitor with an IC50 of 25.08 nM. It exhibits broad-spectrum anticancer activity, showing effectiveness against leukemia, melanoma, and breast cancer, while demonstrating no significant cytotoxicity to normal Vero cells (mean IC50 values are 2.87, 3.65, 3.79, and 45.48 μM, respectively) .
Field of Research
Cell Biology, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19233951-01CDK8/19-IN-2
GTR19201402-01CDK8/19-IN-51
GTR19206280-01CDK8/19-IN-1
GTR19249668-01CDK8/19-IN-3
GTR18236783-01CDK8 Antibody
GTR18022091Cdk8 Antibody
GTR18140208Cdk8 Antibody
GTR18584073-01CDK8 Antibody
GTR18579723-01CDK8 Antibody
GTR19186298-01CDK8-IN-5

Alternative Products

CatalogName
HY-176282CDK8-IN-19
T22633-01CDK8/19-IN-51
HY-111427-01CDK8/19-IN-1
HY-168846CDK8/19-IN-3
HY-158377CDK8/19-IN-2
A19857-1Anti-CDK8/19 Antibody
A19986-50CDK8/19-IN-1 50mg
A19986-25CDK8/19-IN-1 25mg
A19986-10CDK8/19-IN-1 10mg
A19986-1CDK8/19-IN-1 1mg

Popular Products